Monday, September 14, 2026

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

NVIDIA Takes a Breather as Blackwell Chip Demand Holds Strong

NVIDIA's stock dipped slightly, but demand for its Blackwell chip remains strong, indicating healthy market conditions.

Anthrax, Plague, and BSL-3 Research: South Korea Checks 47 Safety Items, CCTV, and Records

The KDCA confirmed 100% compliance with biosafety standards in inspections of high-risk pathogen facilities and BSL-3 labs.

Tag: maritime superiority

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.